Cannabis-related psychosis: Presentation and effect of abstinence

Abstract

Background:The correlation between cannabis and negative mental health outcomes has been unequivocally established. Nevertheless, there is still a great need to research different dimensions of cannabis-related disorders, among which the study of cannabis-related psychosis is very important. There is a dearth of research regarding phenomenology and effect of abstinence, particularly from India. This study attempts to research the clinical presentation of cannabis-related psychosis and effect of abstinence.Aim:The aim of the present study was to document the clinical presentation of cannabis-related psychosis at presentation and after 7 days' abstinence from cannabis.Materials and Methods:Subjects with psychosis following cannabis use without any other prior or concurrent psychiatric disorder presenting to the outpatient department of a large tertiary care hospital were consecutively recruited for study. They were observed in a drug-free, protected environment for 7 days, during which clinical features were recorded using the Brief Psychiatric Rating Scale (BPRS).Results:Twenty male subjects were recruited and phenomenology was evaluated on the BPRS. Items with highest frequencies were unusual thought content (100%), excitement (75%), grandiosity (75%), hallucinatory behavior (70%) and uncooperativeness (65%). The least common symptoms were anxiety (5%), guilt feeling (5%), depressive mood (10%), motor retardation (10%) and blunted affect (30%). Nine subjects (45%) presented with cognitive dysfunction. Affective psychosis was the predominant diagnosis. At the end of 1 week of abstinence from cannabis, there was a significant decrease in scores. Significant improvement was observed in cognitive dysfunction, conceptual disorganization, grandiosity, tension, hostility, hallucinatory behavior and excitement.Conclusions:Cannabis-related psychosis presented with a predominantly affective psychosis and prominent thought disorder, excitement and violence. All subjects showed improvement in symptoms with abstinence from cannabis. A small heterogeneous sample and short duration of observation were the important limitations of this study.

Does substance use disorder affect clinical expression in first-hospitalization patients with schizophrenia? Analysis of a prospective cohort

“…Most of the psychopathological dimension found as significantly higher during hospitalization was previously reported as more prevalent in cannabis-related psychosis and cannabis abstinence (Kulhalli et al, 2007). Considering that all SUD patients in our sample are cannabis abusers we could suggest a possible overlap of cannabis induced psychosis with first episode of schizophrenia.…”

Profile of Patients with Dual Diagnosis: Experience from an Integrated Dual Diagnosis Clinic in North India

“…However, cannabis use is relatively more prevalent (23%) in the psychosis group. This finding is also in line with the literature across the world [10][11][12]. Opioid (nonpsychotic-26% and psychotic-28%).…”

A review of Indian research on co-occurring cannabis use disorders& psychiatric disorders

“…Types of studies : Thirty one studies included in the current review were cross-sectional observational studies 7 8 9 10 11 12 13 14 15 17 18 19 20 21 28 33 34 35 36 37 38 40 41 42 43 45 47 49 51 55 56 . Other study types included reviews (nine publications) 23 24 27 30 31 32 39 50 52 , prospective observational studies (three publications) 22 29 44 , retrospective chart reviews (three publications) 26 53 54 , case-control study (one publication) 25 , letter to editor (one publication) 48 , case series (one publication) 10 and editorial (one publication) 46 .…”